Valeant in talks to sell eye surgical products business – Bbg

Canadian drugmaker Valeant
Pharmaceuticals International Inc is in talks
to sell its Bausch & Lomb unit’s surgical products business to
Germany’s Carl Zeiss Meditec AG, Bloomberg reported.

Valeant’s eye-surgery assets may be valued at about $2
billion in a sale, Bloomberg reported, citing people familiar
with the matter. (

Valeant and Carl Zeiss were not immediately available for
(Reporting by Ahmed Farhatha in Bengaluru; Editing by Maju


var median = (relatedItemsTotal / 2);
var $relatedContentGroupOne = $(‘ ul’);
var $relatedContentGroupTwo = $(‘ ul’);

$.each($relatedItems, function(k,v) {
if (k + 1